Search
Filters
-
Isomorphic Labs in Talks at a $40–50B Valuation; No Drug Yet in Human Trials
…: Isomorphic is in talks at a valuation of at least $40 billion and up to $50 billion, five months after a $2.…
…: Isomorphic is in talks at a valuation of at least $40 billion and up to $50 billion, five months after a $2.…